---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/dolphin/post/43601706.md"
description: "Li Auto 2Q26 First Take: Overall, the quarter was fine. Auto GPM missed slightly, but ASP rose more than expected, driving a revenue beat.With decent opex control, profitability roughly met expectations. What disappointed investors was the Q3 guide. Deliveries are guided to just 95–100k units despite a dense slate of mid-cycle refreshes for the L series and concurrent i-series updates (L9 refreshed on May 15, L8 on Jun 23, the new L6 launched in Jul, and a refreshed i8 in Aug).That implies no QoQ volume uplift vs. Q2’s 98k and is well below the Street’s 122k. This suggests that even with a 'spec bump at same price', mid-cycle L-series orders are only mediocre. Competition in large range-extended SUVs is fierce, and even the refreshed L6 has not revived volumes. Revenue guidance of RMB 26.6–28.0bn is likewise well below the RMB 32.7bn consensus. The main reason remains the sizable miss in volume guidance.The implied ASP is RMB 263k, up from Q2’s RMB 245k by nearly RMB 20k, driven by mix shift toward refreshed L9 and L8, but it also underscores weak orders for the refreshed L6. Li Auto had set a 2026 sales target of 480k units (+20% YoY). The first three quarters would total only 283–293k.Given softer-than-expected orders for the volume model, Dolphin Research expects the target to be cut sharply to around 420k, implying only ~3% YoY growth. Selling pressure remains elevated. $Li Auto(LI.US) $LI AUTO-W(02015.HK)"
datetime: "2026-08-26T09:33:03.000Z"
locales:
  - [en](https://longbridge.com/en/dolphin/post/43601706.md)
  - [zh-CN](https://longbridge.com/zh-CN/dolphin/post/43601706.md)
  - [zh-HK](https://longbridge.com/zh-HK/dolphin/post/43601706.md)
author: "[Dolphin Research](https://longbridge.com/en/dolphin.md)"
generator: "portal-rs"
---

# Li Auto 2Q26 First Take: Overall, the quarter was …


### Related Stocks

- [02015.HK](https://longbridge.com/en/quote/02015.HK.md)
- [LI.US](https://longbridge.com/en/quote/LI.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**